Human Mesenchymal Stem Cell Media Search Results


stem cell applications bone marrow derived mesenchymal stem cells mscs  (Cell Applications Inc)
93
Cell Applications Inc stem cell applications bone marrow derived mesenchymal stem cells mscs
Stem Cell Applications Bone Marrow Derived Mesenchymal Stem Cells Mscs, supplied by Cell Applications Inc, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/Human+Mesenchymal+Stem+Cell+Media/pmc11504873-45-0-1?v=Cell+Applications+Inc
Average 93 stars, based on 1 article reviews
stem cell applications bone marrow derived mesenchymal stem cells mscs - by Bioz Stars, 2026-07
93/100 stars
  Buy from Supplier
mesenchymal stem cell complete media with serum  (Celprogen Inc)
92
Celprogen Inc mesenchymal stem cell complete media with serum
(a–c) Characterization and quantification of human-bone marrow <t>mesenchymal</t> stem cell (hBM-MSC)-derived extracellular vesicles (EVs). (a) Nanosight Tracking analyses (NTA) showing the size distribution pattern of EVs. (b) Western blots of hBM-MSCs marker (GM130) and EVs markers (ALIX, CD9, CD81). “Wash” lane represents the negative control. Each image comes from different blots. (c) Representative image of EVs using transmission electron microscopy (TEM). Scale bar 100 nm. (d–f) In vivo tracking of ExoGlow-labeled EVs demonstrated that EVs reach the brain and accumulate near the stroke injury 6 hours after administration at 2 dps. (d) Timeline of intranasal single dose treatment of ExoGlow-labeled EVs (~2.4 x 10 9 EVs in 200 μl), starting 2 dps and collecting the tissue 6 hours after. (e) Representative coronal section after a single intranasal administration of ExoGlow-labeled EVs (~2.4 x 10 9 EVs in 200 μl) at 2 dps. Hoechst indicates cell nuclei. Scale bars 4 mm and 100 μm. (f) Quantification of the average size of ExoGlow+ particles in the ipsilateral and contralateral hemispheres. Data was analyzed using a paired t-test (*p<0.05). Bars show mean +/− SD. Each symbol represents the average size of ExoGlow+ particles from all ROIs in each hemisphere (5 ROIs/hemisphere in each rat) of a single rat ( n = 4 ).
Mesenchymal Stem Cell Complete Media With Serum, supplied by Celprogen Inc, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/Human+Mesenchymal+Stem+Cell+Media/pmc11493303-130-9-16?v=Celprogen+Inc
Average 92 stars, based on 1 article reviews
mesenchymal stem cell complete media with serum - by Bioz Stars, 2026-07
92/100 stars
  Buy from Supplier
bone marrow  (Celprogen Inc)
92
Celprogen Inc bone marrow
(a–c) Characterization and quantification of human-bone marrow <t>mesenchymal</t> stem cell (hBM-MSC)-derived extracellular vesicles (EVs). (a) Nanosight Tracking analyses (NTA) showing the size distribution pattern of EVs. (b) Western blots of hBM-MSCs marker (GM130) and EVs markers (ALIX, CD9, CD81). “Wash” lane represents the negative control. Each image comes from different blots. (c) Representative image of EVs using transmission electron microscopy (TEM). Scale bar 100 nm. (d–f) In vivo tracking of ExoGlow-labeled EVs demonstrated that EVs reach the brain and accumulate near the stroke injury 6 hours after administration at 2 dps. (d) Timeline of intranasal single dose treatment of ExoGlow-labeled EVs (~2.4 x 10 9 EVs in 200 μl), starting 2 dps and collecting the tissue 6 hours after. (e) Representative coronal section after a single intranasal administration of ExoGlow-labeled EVs (~2.4 x 10 9 EVs in 200 μl) at 2 dps. Hoechst indicates cell nuclei. Scale bars 4 mm and 100 μm. (f) Quantification of the average size of ExoGlow+ particles in the ipsilateral and contralateral hemispheres. Data was analyzed using a paired t-test (*p<0.05). Bars show mean +/− SD. Each symbol represents the average size of ExoGlow+ particles from all ROIs in each hemisphere (5 ROIs/hemisphere in each rat) of a single rat ( n = 4 ).
Bone Marrow, supplied by Celprogen Inc, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/Human+Mesenchymal+Stem+Cell+Media/pmc11493303-134-3-10?v=Celprogen+Inc
Average 92 stars, based on 1 article reviews
bone marrow - by Bioz Stars, 2026-07
92/100 stars
  Buy from Supplier
human bone marrow derived mesenchymal stem cell complete media with serum  (Celprogen Inc)
92
Celprogen Inc human bone marrow derived mesenchymal stem cell complete media with serum
(a–c) Characterization and quantification of human-bone marrow <t>mesenchymal</t> stem cell (hBM-MSC)-derived extracellular vesicles (EVs). (a) Nanosight Tracking analyses (NTA) showing the size distribution pattern of EVs. (b) Western blots of hBM-MSCs marker (GM130) and EVs markers (ALIX, CD9, CD81). “Wash” lane represents the negative control. Each image comes from different blots. (c) Representative image of EVs using transmission electron microscopy (TEM). Scale bar 100 nm. (d–f) In vivo tracking of ExoGlow-labeled EVs demonstrated that EVs reach the brain and accumulate near the stroke injury 6 hours after administration at 2 dps. (d) Timeline of intranasal single dose treatment of ExoGlow-labeled EVs (~2.4 x 10 9 EVs in 200 μl), starting 2 dps and collecting the tissue 6 hours after. (e) Representative coronal section after a single intranasal administration of ExoGlow-labeled EVs (~2.4 x 10 9 EVs in 200 μl) at 2 dps. Hoechst indicates cell nuclei. Scale bars 4 mm and 100 μm. (f) Quantification of the average size of ExoGlow+ particles in the ipsilateral and contralateral hemispheres. Data was analyzed using a paired t-test (*p<0.05). Bars show mean +/− SD. Each symbol represents the average size of ExoGlow+ particles from all ROIs in each hemisphere (5 ROIs/hemisphere in each rat) of a single rat ( n = 4 ).
Human Bone Marrow Derived Mesenchymal Stem Cell Complete Media With Serum, supplied by Celprogen Inc, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/Human+Mesenchymal+Stem+Cell+Media/10__46332_slash_aemj__1493279-32-5-18?v=Celprogen+Inc
Average 92 stars, based on 1 article reviews
human bone marrow derived mesenchymal stem cell complete media with serum - by Bioz Stars, 2026-07
92/100 stars
  Buy from Supplier
msc  (Celprogen Inc)
90
Celprogen Inc msc
(a–c) Characterization and quantification of human-bone marrow <t>mesenchymal</t> stem cell (hBM-MSC)-derived extracellular vesicles (EVs). (a) Nanosight Tracking analyses (NTA) showing the size distribution pattern of EVs. (b) Western blots of hBM-MSCs marker (GM130) and EVs markers (ALIX, CD9, CD81). “Wash” lane represents the negative control. Each image comes from different blots. (c) Representative image of EVs using transmission electron microscopy (TEM). Scale bar 100 nm. (d–f) In vivo tracking of ExoGlow-labeled EVs demonstrated that EVs reach the brain and accumulate near the stroke injury 6 hours after administration at 2 dps. (d) Timeline of intranasal single dose treatment of ExoGlow-labeled EVs (~2.4 x 10 9 EVs in 200 μl), starting 2 dps and collecting the tissue 6 hours after. (e) Representative coronal section after a single intranasal administration of ExoGlow-labeled EVs (~2.4 x 10 9 EVs in 200 μl) at 2 dps. Hoechst indicates cell nuclei. Scale bars 4 mm and 100 μm. (f) Quantification of the average size of ExoGlow+ particles in the ipsilateral and contralateral hemispheres. Data was analyzed using a paired t-test (*p<0.05). Bars show mean +/− SD. Each symbol represents the average size of ExoGlow+ particles from all ROIs in each hemisphere (5 ROIs/hemisphere in each rat) of a single rat ( n = 4 ).
Msc, supplied by Celprogen Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/Human+Mesenchymal+Stem+Cell+Media/pmc05636619-147-40-43?v=Celprogen+Inc
Average 90 stars, based on 1 article reviews
msc - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier
bfgf-loaded human mesenchymal stem cell growth media  (Lonza)
90
Lonza bfgf-loaded human mesenchymal stem cell growth media
(a–c) Characterization and quantification of human-bone marrow <t>mesenchymal</t> stem cell (hBM-MSC)-derived extracellular vesicles (EVs). (a) Nanosight Tracking analyses (NTA) showing the size distribution pattern of EVs. (b) Western blots of hBM-MSCs marker (GM130) and EVs markers (ALIX, CD9, CD81). “Wash” lane represents the negative control. Each image comes from different blots. (c) Representative image of EVs using transmission electron microscopy (TEM). Scale bar 100 nm. (d–f) In vivo tracking of ExoGlow-labeled EVs demonstrated that EVs reach the brain and accumulate near the stroke injury 6 hours after administration at 2 dps. (d) Timeline of intranasal single dose treatment of ExoGlow-labeled EVs (~2.4 x 10 9 EVs in 200 μl), starting 2 dps and collecting the tissue 6 hours after. (e) Representative coronal section after a single intranasal administration of ExoGlow-labeled EVs (~2.4 x 10 9 EVs in 200 μl) at 2 dps. Hoechst indicates cell nuclei. Scale bars 4 mm and 100 μm. (f) Quantification of the average size of ExoGlow+ particles in the ipsilateral and contralateral hemispheres. Data was analyzed using a paired t-test (*p<0.05). Bars show mean +/− SD. Each symbol represents the average size of ExoGlow+ particles from all ROIs in each hemisphere (5 ROIs/hemisphere in each rat) of a single rat ( n = 4 ).
Bfgf Loaded Human Mesenchymal Stem Cell Growth Media, supplied by Lonza, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/Human+Mesenchymal+Stem+Cell+Media/us08691543-345-7-13?v=Lonza
Average 90 stars, based on 1 article reviews
bfgf-loaded human mesenchymal stem cell growth media - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier
human mesenchymal stem cell serum free expansion media  (Celprogen Inc)
N/A
Human Mesenchymal Stem Cell (Cord Blood Derived) Serum Free Expansion Media. This product is also available with Serum Cat# M36001-03ES This product would require pre-coated flasks with Human Mesenchymal Stem Cell (Cord Blood Derived) Extra-cellular
   Buy from Supplier
human mesenchymal stem cell freezing media  (Celprogen Inc)
N/A
Human (Bone Marrow derived) Mesenchymal Stem Cell Freezing Media Optimized for freezing Human (Bone Marrow derived) Mesenchymal Stem Cell Cat# 36094-21. This product is tissue culture tested and is available as 100ml sterile filtered unit.
   Buy from Supplier
human mesenchymal stem cell serum free un-differentiation media  (Celprogen Inc)
N/A
Human Mesenchymal Stem Cell (Cord Blood Derived) Serum Free Un-differentiation Media. This product is also available with Serum Cat# M36001-03US This product would require pre-coated flasks with Human Mesenchymal Stem Cell (Cord Blood Derived) Extra-cellular
   Buy from Supplier
human mesenchymal bone marrow derived stem cell un-differentiation media with serum  (Celprogen Inc)
N/A
Human Mesenchymal Bone Marrow (Adult) Derived Stem Cell Un-differentiation Media with Serum. This product is also available without Serum Cat# M36094-22U This product would require pre-coated flasks with Human Mesenchymal Bone Marrow (Adult) Derived Stem
   Buy from Supplier
human mesenchymal stem cell expansion media with serum  (Celprogen Inc)
N/A
Human Mesenchymal Stem Cell (Cord Blood Derived) Expansion Media with Serum. This product is also available without Serum Cat# M36001-03E This product would require pre-coated flasks with Human Mesenchymal Stem Cell (Cord Blood Derived) Extra-cellular
   Buy from Supplier

Image Search Results


(a–c) Characterization and quantification of human-bone marrow mesenchymal stem cell (hBM-MSC)-derived extracellular vesicles (EVs). (a) Nanosight Tracking analyses (NTA) showing the size distribution pattern of EVs. (b) Western blots of hBM-MSCs marker (GM130) and EVs markers (ALIX, CD9, CD81). “Wash” lane represents the negative control. Each image comes from different blots. (c) Representative image of EVs using transmission electron microscopy (TEM). Scale bar 100 nm. (d–f) In vivo tracking of ExoGlow-labeled EVs demonstrated that EVs reach the brain and accumulate near the stroke injury 6 hours after administration at 2 dps. (d) Timeline of intranasal single dose treatment of ExoGlow-labeled EVs (~2.4 x 10 9 EVs in 200 μl), starting 2 dps and collecting the tissue 6 hours after. (e) Representative coronal section after a single intranasal administration of ExoGlow-labeled EVs (~2.4 x 10 9 EVs in 200 μl) at 2 dps. Hoechst indicates cell nuclei. Scale bars 4 mm and 100 μm. (f) Quantification of the average size of ExoGlow+ particles in the ipsilateral and contralateral hemispheres. Data was analyzed using a paired t-test (*p<0.05). Bars show mean +/− SD. Each symbol represents the average size of ExoGlow+ particles from all ROIs in each hemisphere (5 ROIs/hemisphere in each rat) of a single rat ( n = 4 ).

Journal: PLOS ONE

Article Title: Recovery after human bone marrow mesenchymal stem cells (hBM-MSCs)-derived extracellular vesicles (EVs) treatment in post-MCAO rats requires repeated handling

doi: 10.1371/journal.pone.0312298

Figure Lengend Snippet: (a–c) Characterization and quantification of human-bone marrow mesenchymal stem cell (hBM-MSC)-derived extracellular vesicles (EVs). (a) Nanosight Tracking analyses (NTA) showing the size distribution pattern of EVs. (b) Western blots of hBM-MSCs marker (GM130) and EVs markers (ALIX, CD9, CD81). “Wash” lane represents the negative control. Each image comes from different blots. (c) Representative image of EVs using transmission electron microscopy (TEM). Scale bar 100 nm. (d–f) In vivo tracking of ExoGlow-labeled EVs demonstrated that EVs reach the brain and accumulate near the stroke injury 6 hours after administration at 2 dps. (d) Timeline of intranasal single dose treatment of ExoGlow-labeled EVs (~2.4 x 10 9 EVs in 200 μl), starting 2 dps and collecting the tissue 6 hours after. (e) Representative coronal section after a single intranasal administration of ExoGlow-labeled EVs (~2.4 x 10 9 EVs in 200 μl) at 2 dps. Hoechst indicates cell nuclei. Scale bars 4 mm and 100 μm. (f) Quantification of the average size of ExoGlow+ particles in the ipsilateral and contralateral hemispheres. Data was analyzed using a paired t-test (*p<0.05). Bars show mean +/− SD. Each symbol represents the average size of ExoGlow+ particles from all ROIs in each hemisphere (5 ROIs/hemisphere in each rat) of a single rat ( n = 4 ).

Article Snippet: Cells were maintained and expanded with human (bone marrow-derived) mesenchymal stem cell complete media with serum (Celprogen, #M36094-21S) at 37°C in a 5% CO 2 atmosphere.

Techniques: Derivative Assay, Western Blot, Marker, Negative Control, Transmission Assay, Electron Microscopy, In Vivo, Labeling